Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Gamida Cell (GMDA) shares
Learn how to easily invest in Gamida Cell shares.
Gamida Cell is a biotechnology business based in the US. Gamida Cell stocks (GMDA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.13 – an increase of 30.4% over the previous week. Gamida Cell employs 110 staff and has a market cap (total outstanding stock value) of $134.6 million.
How to buy shares in Gamida Cell
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GMDA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Gamida Cell?
- Has coronavirus impacted Gamida Cell shares?
- Gamida Cell shares summary
- Compare share dealing platforms
- Is Gamida Cell stock a buy or sell?
- Gamida Cell performance over time
- Gamida Cell's financials
- How volatile are Gamida Cell shares?
- Does Gamida Cell pay a dividend?
- Other common questions
Gamida Cell stock price (NASDAQ:GMDA)Use our graph to track the performance of GMDA stocks over time.
Gamida Cell shares at a glance
|Latest market close||$2.96|
|52-week range||$2.10 - $15.00|
|50-day moving average||$2.77|
|200-day moving average||$4.90|
|Wall St. target price||$15.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.79|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Gamida Cell stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Gamida Cell price performance over time
|1 week (2022-01-14)||30.40%|
|1 month (2021-12-21)||16.54%|
|3 months (2021-10-21)||-28.67%|
|6 months (2021-07-21)||-49.40%|
|1 year (2021-01-21)||-66.93%|
|2 years (2020-01-21)||-36.14%|
|3 years (2019-01-18)||10.8|
|5 years (2017-01-17)||N/A|
Gamida Cell financials
|Gross profit TTM||$0|
|Return on assets TTM||-41.17%|
|Return on equity TTM||-171.34%|
|Market capitalisation||$134.6 million|
TTM: trailing 12 months
Gamida Cell share dividends
We're not expecting Gamida Cell to pay a dividend over the next 12 months.
Gamida Cell share price volatility
Over the last 12 months, Gamida Cell's shares have ranged in value from as little as $2.1 up to $15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gamida Cell's is 1.904. This would suggest that Gamida Cell's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Gamida Cell overview
Gamida Cell Ltd. , a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel. .
Gamida Cell in the news
Netflix quietly admits streaming competition is eating into growth
Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More
38 Stocks Moving In Thursday's Mid-Day Session
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.